Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593268 · ClinicalTrials.gov registry record
Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage
A clinical trial of Subarachnoid Hemorrhage, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT00593268 is a study of Subarachnoid Hemorrhage that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 150 participants, below the 3,581-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00593268, a study of Subarachnoid Hemorrhage, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
In this project we are collecting cerebrospinal fluid and blood from patients at Vanderbilt Medical Center who have a subarachnoid hemorrhage which has followed the rupture of a brain aneurysm. We then propose to study the cerebrospinal fluid using a novel microscopic laser directed mass spectrometric analysis (MALDI) available at Vanderbilt. The cerebrospinal fluid and blood will then be analysed for different biological markers, protein expression and gene expression. These markers will then be statistically correlated with clinical data including prediction of vasospasm, time to vasospasm and response to standard therapy.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center, Department of Neurological Surgery - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2004-06 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00593268
The ClinicalTrials.gov registry entry for NCT00593268 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,581-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (96% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 0 interventions.
NCT00593268 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00593268 about?
NCT00593268 is a clinical study titled "Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage". In this project we are collecting cerebrospinal fluid and blood from patients at Vanderbilt Medical Center who have a subarachnoid hemorrhage which has followed the rupture of a brain aneurysm. We then propose to study the cerebrospinal fluid using a novel microscopic laser directed mass spectrometr...
What is the current status of trial NCT00593268?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2004-06. Estimated completion is 2028-12.
What conditions does trial NCT00593268 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage.
Who is sponsoring clinical trial NCT00593268?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00593268 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Auricular VNS Following Subarachnoid Hemorrhage
RECRUITING · NA
-
Optical Coherence Tomography Angiography in Neurological Disease
RECRUITING
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.